333 related articles for article (PubMed ID: 16503315)
1. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
Franco KN; Messinger-Rapport B
J Am Med Dir Assoc; 2006 Mar; 7(3):201-2. PubMed ID: 16503315
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
Sink KM; Holden KF; Yaffe K
JAMA; 2005 Feb; 293(5):596-608. PubMed ID: 15687315
[TBL] [Abstract][Full Text] [Related]
3. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
[TBL] [Abstract][Full Text] [Related]
4. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological treatment of behavioral symptoms in dementia patients].
Gabryelewicz T
Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.
Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G
J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323
[TBL] [Abstract][Full Text] [Related]
8. Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms.
Woodward MR; Harper DG; Stolyar A; Forester BP; Ellison JM
Am J Geriatr Psychiatry; 2014 Apr; 22(4):415-9. PubMed ID: 23597932
[TBL] [Abstract][Full Text] [Related]
9. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
10. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.
Ballard C; Corbett A; Chitramohan R; Aarsland D
Curr Opin Psychiatry; 2009 Nov; 22(6):532-40. PubMed ID: 19696673
[TBL] [Abstract][Full Text] [Related]
11. Benefits and harms of atypical antipsychotics for agitation in adults with dementia.
Farlow MR; Shamliyan TA
Eur Neuropsychopharmacol; 2017 Mar; 27(3):217-231. PubMed ID: 28111239
[TBL] [Abstract][Full Text] [Related]
12. Agitation. How to manage behavior disturbances in the older patient with dementia.
Neugroschl J
Geriatrics; 2002 Apr; 57(4):33-7; quiz 40. PubMed ID: 11974389
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.
Pollock BG; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Huber KA
Am J Geriatr Psychiatry; 2007 Nov; 15(11):942-52. PubMed ID: 17846102
[TBL] [Abstract][Full Text] [Related]
14. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
Mercer D; Douglass AB; Links PS
J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
[TBL] [Abstract][Full Text] [Related]
15. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
Wilcock GK; Ballard CG; Cooper JA; Loft H
J Clin Psychiatry; 2008 Mar; 69(3):341-8. PubMed ID: 18294023
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol for agitation in dementia.
Lonergan E; Luxenberg J; Colford J
Cochrane Database Syst Rev; 2001; (4):CD002852. PubMed ID: 11687166
[TBL] [Abstract][Full Text] [Related]
17. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
Freund-Levi Y; Jedenius E; Tysen-Bäckström AC; Lärksäter M; Wahlund LO; Eriksdotter M
Am J Geriatr Psychiatry; 2014 Apr; 22(4):341-8. PubMed ID: 24035407
[TBL] [Abstract][Full Text] [Related]
18. Treatment of delusions in dementia with Lewy bodies - response to pharmacotherapy.
Fischer C; Bozanovic R; Atkins JH; Rourke SB
Dement Geriatr Cogn Disord; 2007; 23(5):307-11. PubMed ID: 17356274
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
20. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]